Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs HCW Biologics Inc. (HCWB)

Aptevo Therapeutics Inc. and HCW Biologics Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and HCW Biologics Inc. are of similar size ($2.3M and $2.3M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against 92.9%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −329.4%) and the higher return on invested capital (0.00% vs −36.2%). Across the 17 metrics below, Aptevo Therapeutics Inc. leads on 10 and HCW Biologics Inc. on 7.

Valuation

Metric APVO HCWB Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 0.20 9.40
P/B 0.25 0.18 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 n/m 0.66
EV/Sales (0.37) 1.12 9.02
Earnings yield (4,659.10%) (2,786.94%) (32.88%)
Free cash flow yield (1,718.19%) (915.31%) (23.13%)

Profitability

Metric APVO HCWB Biotechnology median
Gross margin 0.00% 95.91% 68.51%
Operating margin 0.00% (114.02%) 0.00%
Net margin 0.00% (329.38%) 0.00%
Free cash flow margin 0.00% (180.57%) 0.00%
Return on equity (446.89%) (600.32%) (51.96%)
Return on assets (186.29%) (79.52%) (46.06%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric APVO HCWB Biotechnology median
Revenue growth (TTM) 92.94% 706.96% 6.76%
EPS growth (last fiscal year) 99.72% 65.49% 29.88%
Revenue growth, 5-year CAGR (26.64%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 2.08 0.06 4.97
Net debt to EBITDA 0.83 (0.40) 1.01

Dividend

Metric APVO HCWB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO HCWB Biotechnology median
Market cap 2.30m 2.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack